Highlights Virbac

Equities

Market Closed - Euronext Paris Other stock markets 16:35:14 08/05/2024 BST			5-day change	1st Jan Change
358 ^EUR	+2.73%		+3.17%	-0.42%

05-03	VIRBAC : Virbac remains an attractive animal healthcare play
04-17	VIRBAC : A healthy start to 2024; outlook re-iterated

VIRBAC : Virbac remains an attractive animal healthcare play	05-03
VIRBAC : A healthy start to 2024; outlook re-iterated	04-17
Virbac: sales up by almost 10% in Q1	04-17	CF
Virbac: 'strategic' acquisition of Sasaeah in Japan	04-02	CF
Virbac SA acquired Sasaea Holdings Co., Ltd. from ORIX Corporation.	03-31	CI
VIRBAC : Oddo BHF maintains its recommendation on the stock	03-21	CF
CAC40: damage limited despite Kering's fall	03-20	CF
Virbac: net income unchanged overall in 2023	03-20	CF
Virbac Sa Provides Earnings Guidance for the Year 2024	03-19	CI
Virbac Sa Proposes Dividend for the Year 2023	03-19	CI
Virbac SA Reports Earnings Results for the Full Year Ended December 31, 2023	03-18	CI
Virbac to Buy Orix's Animal Health Unit	03-06	MT
Virbac: acquisition of Sasaeah in Japan	03-06	CF
Virbac SA entered into a definitive agreement to acquire Sasaea Holdings Co., Ltd. from ORIX Corporation for an enterprise value of approximately ?280 million.	03-05	CI
VIRBAC : Modest beat in Q4; 2024 outlook maintained	01-18
VIRBAC : Stifel raises its target price	01-18	CF
Virbac: sales up 4.6% in 2023	01-17	CF
Virbac SA Provides Earnings Guidance for the Year 2024	01-17	CI
Virbac: one of the SBF120's top performers in 2023	12-29	CF
France's Virbac Takes Majority Stake in Indian Poultry Vaccines Group Globion	11-03	MT

No results for this search

VIRBAC : Virbac remains an attractive animal healthcare play

May 03, 2024 at 02:06 pm